6WY-20686-40746
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 253 / WV
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-22
- 2021-01-01
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-11
- 2021-01-13
- 2021-01-14
- 2021-01-26
- 2021-02-02
- 2021-02-10
- 2021-02-15
- 2021-02-24
- 2021-04-18
- 2021-07-12
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2021-10-11
Survey response — days 1–6 daily, dose 3MedDRA: Anosmia, Dyspnoea — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to work or attend schoolFree text: Anosmia, shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Survey response — days 1–6 daily, dose 3MedDRA: Adverse reaction, SARS-CoV-2 test positive — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: I had a positive COVID PCR on 10/11, so my symptoms are related to diseaseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Anosmia, shortness of breath
Systemic reaction (other): I had a positive COVID PCR on 10/11, so my symptoms are related to disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Anosmia | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release